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RECRUITMENT, SINGLE VENTRICULAR PALLIATION, AND COMPLEX 
BIVENTRCULAR REPAIR FOR PATIENTS WITH HYPOPLASTIC LEFT 
HEART SYNDROME  
VIVIAN WU 
ABSTRACT 
Background: Hypoplastic Left Heart Syndrome is a congenital birth defect that is 
defined by underdevelopment of the left heart during pregnancy. This is especially 
dangerous as the left heart holds the systemic flow of blood- the oxygenated blood. Not 
enough oxygen throughout the whole body causes cyanosis, which symptoms include 
bluish discoloration of the skin or mucous membrane due to low oxygen saturation. 
Single Ventricle Palliation followed by Biventricular Conversion is the most common 
surgical procedural pathway to correct this defect. The goal is to convert from a single 
ventricle circulation during single ventricle palliation to biventricular circulation via 
biventricular conversion, which is the normal heart anatomy. Single Ventricle Pallation 
consists of three stages: Stage 1 Norwood Procedure, Bidirectional Glenn, and Fontan. 
Biventricular Conversion can be performed after any of the three stages. In addition, 
further compromise of the left ventricle includes other factors such as a thickening of 
fibroblast-like cells on the endocardial layer called endocardial fibroelastosis. Therefore, 
additional surgical procedures, also known as recruitment procedures, combat these 
problems. It is critical to find a correlation between a specific procedure and post surgery 
success in left ventricle growth and function for these patients.  
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Objectives: Patients with Hypoplastic Left Heart Syndrome at Boston Children’s 
Hospital have undergone single ventricle palliation with some patients proceeding to 
biventricular conversion. This study aimed to study the palliation stages individually and 
recruitment procedures (specifically endocardial fibroelastosis resection) on the effect of 
left ventricle growth.  
Methods: Patients with Hypoplastic Left Heart Syndrome were studied retrospectively 
(before 2014) and prospectively (after 2014 until December 1, 2018). Single Ventricle 
Palliation and Biventricular Conversion were analyzed via descriptional analysis with 
evidence of left ventricular growth measured by left ventricular end diastolic volume and 
respective z-scores. Z-scores were used to standardize end diastolic volume values across 
variability in age, weight, and height.  
Results: A total of 55 patients underwent single ventricle palliation and 39 ended with 
biventricular circulation via biventricular conversion. Overall, there was a 9.29 ml 
increase in end diastolic volume between Bidirectional Glenn and Fontan and a 0.795 
increase in end diastolic volume z-score between Fontan and Biventricular Conversion. 
Next, those who did not have recruitment procedures experienced a 135.6%, 48.8%, and 
0% growth at Stage 1, Bidirectional Glenn, and Fontan, respectively, before directly 
proceeding to biventricular conversion. Those with recruitment experienced a 44.5%, 
90.4%, and 83.0% growth at Stage 1, Bidirectional Glenn, and Fontan, respectively, 
before directly proceeding to biventricular conversion. Finally, there was a 50.2% and 
62.3% in left ventricular growth at Bidirectional Glenn and Fontan, respectively, after 
endocardial fibroelastosis resection compared to only a 6.9% growth at Stage 1.  
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Conclusion: Bidirectional Glenn was the most effective palliation stage for left 
ventricular growth. Recruitment in patients at this stage was associated with growth that 
exceeds those who did not have recruitment. This stage also best demonstrates the ability 
and success of growing a small ventricle to be adequate for biventricular conversion. Left 
ventricular growth at Fontan circulation holds promising results that are a point of 
interest for more studies. Endocardial Fibroelastosis resection is more effective on left 
ventricular growth at Bidirectional Glenn and Fontan compared to Stage 1. 
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INTRODUCTION 
The goal of this study is to determine the following two things: stage in Single 
Ventricle Palliation (SVP) that is the most effective in stimulating left ventricular (LV) 
growth and stage which recruitment is the most effective, especially the impact of 
endocardial fibroelastosis (EFE) on LV growth. Determining which stage with the most 
promising LV growth can introduce discussion of critical time points to perform certain 
procedures that may maximize successful conversion from singular ventricular 
circulation to biventricular circulation (BIV) via biventricular conversion (BiVC).  It is 
the same reasoning for purpose of recruitment effectiveness. 
 
Hypoplastic Left Heart Syndrome (HLHS) 
Among congenital defects in neonates, heart defects prove the most common with 
3-12 per 1000 births with the risk rising two-fold for premature infants (Gładki et al., 
2015). One major congenital heart defect is Hypoplastic Left Heart Syndrome (HLHS). 
HLHS affects boys more than girls (two thirds of cases occur in boys) and is the most 
common cause of cardiac-related death in the first month of life (Toebbe et al., 2013)  It 
is defined as the general underdevelopment of the left ventricle and its dependent 
structures such as the mitral valve, aortic valve, and preductal and ductal aorta (Mettler & 
Pigula, 2016). In addition, pulmonary and systemic ventricles for biventricular circulation 
are often compromised for severe HLHS patients, which left ventricular hypoplasia 
and/or valve atresia are hallmarks (Banka et al., 2014).  
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Figure 1. Comparison between a normal heart and a heart with HLHS (Toebbe et 
al., 2013). Patent ductus arteriosus (PDA) is a connection between pulmonary artery and 
aorta that is usually closed shortly after birth. A persistent opening indicates mix of 
pulmonary and systemic blood. Atrial Septal Defect (ASD), an opening between the 
atrium, is further mixing of the systemic and pulmonary blood that causes problems such 
as cyanosis.   
 
With the left ventricle’s function compromised, these neonates will commonly be 
seen in severe respiratory distress, respiratory acidosis, and cyanosis immediately after 
birth (Mettler & Pigula, 2016). The following are two surgical pathways to attempt to 
combat HLHS: single ventricle palliation (SVP) and biventricular conversion (BiVC). 
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Single Ventricle Palliation (SVP) 
  There are three stages of SVP. Stage I is the Norwood Procedure, stage II is the 
Bidirectional Glenn (BDG), and stage III is the Fontan. SVP’s objective is to utilize the 
right heart as both pulmonary and systemic circulation to alleviate obstruction of left 
heart’s blood flow when left heart is compromised. Stage 1 Norwood Procedure is often 
performed shortly after birth for survival. This procedure encompasses all of the 
following steps but not necessarily in this order: Blalock-Taussig shunt (BTS), side to 
side anastomosis between aorta and pulmonary valve, aortic arch augmentation with a 
piece of pulmonary homograft, and atrial septectomy (Mettler & Pigula, 2016). Atrial 
septectomy allows blood from the LA to enter RA and this increase in total volume of 
blood in to the RV will leave through the augmented aortic arch and to the body. BTS 
provides additional pulmonary blood flow to prevent cyanosis. 
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Figure 2. Stage I: The Heart after Norwood Procedure  
is Performed. Increased systemic flow by this procedure relieves 
the hypoplastic left heart (HLH) from working excessively to provide 
an adequate amount of blood to the body. BT Shunt ensures blood volume to 
pulmonary blood flow is still sufficient (Human, 2009) 
 
 The interstage mortality rate between Norwood procedure and stage II palliation 
is of significance; it remains as high as 8% to 12% (Oster et al., 2016). Due to the 
statistics, performing stage II BDG early may seem tempting to solve this high interstage 
mortality; however, it is proven that performing early BDG on patients younger than two 
months of age resulted in a reoperation rate of 17%. Therefore, stage II BDG is 
postponed for a neonate until after three months of age (Mettler & Pigula, 2016).  
 The purposes of stage II BDG is to further decrease the amount of blood going 
through the ventricles and shunt it towards the lungs in hopes of increasing oxygen 
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saturation. The goal of this procedure is to connect the superior vena cava (SVC) to the 
pulmonary artery (PA) so that the blood flow from the head circumvents the right 
ventricle and to the lungs. To do so, the azygous vein is severed, the pulmonary remnant 
of BTS is excised, and the pulmonary arteriotomy is enlarged to accommodate the SVC. 
After the SVC is clamped at its insertion into the RA, anastomosis is performed with a 
suture between SVC and PA (Mettler & Pigula, 2016).    
 
 
Figure 3. Stage II: The Heart after BDG is performed. 
By attachment of SVC to PA, the blood from the head bypasses 
RA and flows directly to the lungs. More blood is shunted towards 
the lungs to increase saturation and relieves the demands on the heart. 
 
 The final stage of SVP is stage III Fontan. The goal of this procedure is to divert 
all systemic venous return to the pulmonary circuit- allowing a physiologic septation of 
	  6 
circulation. The are two types of Fontan- extracardiac and lateral tunnel; however, 
extracardiac Fontan is preferred as it is more hemodynamically efficient (Mettler & 
Pigula, 2016). The lateral tunnel of a Fontan is a baffle (or tunnel) that connects the 
inferior vena cava (IVC) to SVC through the right atrium so the deoxygenated blood 
from the lower part of the body circumvents the RA, but still leads to the PA. The 
extracardiac tunnel is a conduit that connects RV to PA, which follows the natural path of 
blood flow.   
 
Figure 4. Stage III: The Heart after Fontan is performed. 
A physiological septation is established with the RH pumping 
blood received from LA and venous return from SVC and 
IVC flows directly in to PA. 
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Biventricular Conversion (BiVC) 
Biventricular conversion (BiVC) is the conversion of SVP to biventricular 
circulation. The objective for BiVC is to avoid SVP’s long-term complications. Some of 
these complications for Fontan circulation are arrhythmias, thromboembolic events, 
hepatic dysfunction, protein-losing enteropathy, exercise intolerance, and neurocognitive 
defects (Kalish et al., 2013). To convert from single ventricular circulation to 
biventricular, there must be a re-establishment of separate LV and RV outflow tract. 
Biventricular conversion can be performed after any stage of SVP as long as the LV 
meets the criteria in size and function; echocardiographic measures of a larger LV EDV, 
LV-to-RV stroke volume ratio, and mitral-to-tricuspid inflow ratio have indicated a 
higher association with successful BiVC (Banka et al., 2014). Therefore, procedures for 
conversion vary for different patients. Example of some procedures performed for BiVC 
are takedown of the aortopulmonary anastomosis and/or reconnecting SVC from the PA 
to the RA (after BDG) (Emani et al., 2012) . 
 
Staged LV Recruitment  
  Staged LV Recruitment strategy is a combination of surgical techniques that can 
complement the Norwood procedure, BDG, or Fontan, or as separate methods. The 
purpose of this strategy is to promote LV growth with the preparation of ultimately 
establishing a functional biventricular circulation through BiVC. Growing and increasing 
the LV size will increase the chance of success and sustained biventricular circulation. 
Some of the techniques applied are resection of endocardial fibroelastosis (EFE), mitral 
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valvuloplasty, aortic valvuloplasty, and atrial septal defect restriction (Emani et al., 
2012).  
Endocardial Fibroelastosis (EFE) is the thickening of the endocardial layer 
composed of spindle shaped fibroblast-like cells among abundant collagenous tissue and 
elastic fibers (Ursell et al., 1984). EFE is a crucial threat because it restricts growth of the 
LV. Furthermore, fetal imaging proves that EFE development is associated with 
distended, poorly contractile LV in HLHS patients (Shimada et al., 2015). Therefore, 
EFE resection is an important method associated in enhancing a patient’s potential LV 
growth.  
Heart valves are important in managing blood pressure and blood flow and when 
compromised, the outflow tract is obstructed. In HLHS, mitral atresia/stenosis and aortic 
atresia/stenosis are common diagnosis. The potential danger caused by faulty valves is 
high, especially because LH retains systemic flow. Therefore, mitral and aortic 
valvuloplasties are valve repair techniques designed to promote sufficient blood flow and 
pressure in LH. These methods for valve repair are part of the LV recruitment strategy 
because repaired valves help increase flow and pressure to the LV, which will cause the 
cardiac muscles to stretch and enlarge the hypoplastic LV.  
A type of atrial septal defect (ASD) restriction often performed is fenestrated 
ASD. Fenestrated ASD uses a fenestrated pericardial patch (4-mm fenestration) to 
establish separate atriums (RA and LA) compared to Norwood procedure where RA and 
LA functioned as one large atrium via atrial septectomy. By restricting ASD, blood 
entering the LA would flow in to LV; thus, the force of blood flow will put pressure on 
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the LV, which will promote LV growth. The reasoning behind ASD restriction via 
fenestrated ASD and not total ASD occlusion is if full occlusion happens, RA pressure 
would increase; this would cause pulmonary blood flow leading to the RA to backtrack, 
leading to pulmonary edema. With fenestration, some flow from RA can enter LA to 
relieve the pressure. 
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METHODS 
 
Study Design  
This is a prospective and retrospective analysis for children who were presented 
to Boston Children’s Hospital with a diagnosis of HLHS.  There are a total of 55 patients; 
25 are retrospective patients and 30 are prospective patients. Retrospective study is 
defined as children who have completed Biventricular Conversion at Boston Children’s 
Hospital in 2014 or before. Prospective study is defined as children who were presented 
from 2014 to December 1, 2018. Hospital records presented in database were analyzed 
for demographics, diagnosis, details of surgical procedures, cardiac magnetic resonance 
imagine (MRI) measurements, and echocardiographic (ECHO) measurements. However, 
only ECHO measurements were used for Left Ventricle End Diastolic Volume (LV 
EDV) and respective Z-scores for this study. ECHO measurements were taken 
immediately before a procedure and right before the next procedure. There may also be 
more ECHO measurements between this time but are not relevant to this study. Primary 
outcomes measures were changes in z-scores for LV EDV as this was a better 
measurement for comparison across the sample of HLHS patients with variation in age, 
weight, and height. Secondary outcomes include current status- alive on a biventricular 
circulation, deceased, takedowns, and/or transplants- and re-operation after BIV 
conversion. 
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Biventricular Conversion Procedure 
 Agreement to BiVC was performed after meticulous assessment from primary 
cardiologist and cardiothoracic surgeons at Boston Children’s Hospital. Some factors 
considered include normal ventricular function, adequate AV valve size and function, and 
low end diastolic pressures (Oladunjoye et al., 2018). 
 
Descriptional Statistics 
 Descriptional analysis was performed using measures of central tendency, with 
median solely used. Since obtained z-scores are from patients with different ages, 
heights, and weights at each palliation procedure, median was used to ensure outliers did 
not skew final measures. Categorical variables include palliation procedures and EFE 
resection at each palliation stage; continuous variables are median z-scores. Use of 
descriptional statistics over analytical statistics for HLHS (N=55) was due to observing 
the trend of recruitment procedures’ efficacy at growing the LV to arrive at our desired 
destination: BIV Conversion for ultimate biventricular circulation. This also allows 
following the secondary outcomes of patients who have undergone both recruitment 
procedures and BIV Conversion to create an overall picture of what a child presented to 
us could possibly expect his or her surgical journey to be like. Furthermore, descriptional 
analysis assists with focusing on the impact of EFE and if it indeed is a significant factor 
in hindering LV growth, which could hinder the success of BiVC.  
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RESULTS 
Patient Characteristics 
 Out of a total of 55 patients, 25 are retrospective patients and 30 are prospective 
patients. Retrospective patients have undergone BIV Conversion in 2014 or before and 
prospective patients are presented from 2014 and onwards. All 55 patients have had 
ECHO performed to measure LV EDV and its respective z-score at and in between each 
SVP procedure.  
 
Table 1. Patient Characteristics (N=55).  55 patients are separated as retrospective and 
prospective and by sex. HLHS affects males more than females. 
Variable Value 
Retrospective, n (%) 
Prospective, n (%) 
25 (45) 
30 (54) 
 
Sex, n (%) 
 
Male  
Female 
 
 
37 (67) 
18 (33) 
 
Overview of Patients’ Palliation Journey 
 Overall, all 55 patients (n=55) had Stage 1 Norwood Procedure, as it is essential 
for HLHS patients’ survival. 44 patients (n=44) of the 55 had BDG. Lastly, 10 patients 
(n=10) of the 55 have had Fontan operation. With choosing to focus on population at 
each stage of SVP, there is an inevitable overlap of patients. Some patients will have 
undergone all procedures- Stage 1, BDG, Fontan, and BiVC- and will, therefore, be 
counted as one patient at each stage.  
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Table 2. Overview of Patients’ Palliation Journey. All patients had Stage 1 Norwood 
Procedure, 80% had a BDG, and 10% had a Fontan. 71% of the 55 patients ultimately 
had BiVC with 38% of this specific population in need of at least one re-operation.  
Variable Value 
SVP, n(%) 
 
Stage 1 
Fontan:  
BiVC: 
 
55 (100) 
4 
39 
BDG 
Fontan:  
BiVC: 
44 (80) 
4 
28 
Fontan  
Fontan:  
BiVC: 
10 (18) 
4 
6 
Biventricular Conversion (BiVC) total, n 
(%) 
 
Re-operations, n (%) 
39 (71) 
 
 
21 (38)* 
*Calculated out of 39 of those who had BiVC 
 
 Thirty-nine of the 55 patients at Stage 1 ended their surgical journey with BiVC 
(ultimate biventricular circulation) while 4 out of the 55 ended as Fontan completion 
(remaining on single ventricular circulation). The median of recruitment procedures from 
Stage 1 to BiVC was one, with a range of 0 to 2.  
 Furthermore, out of the 44 patients that have had BDG, 4 patients stayed on 
Fontan circulation and 28 patients proceeded to BiVC. The median of recruitment 
procedures from BDG to BiVC was one, with a range of 0 to 4.  
 Lastly, of the 10 patients that have had Fontan operation, 6 proceeded to BiVC 
with a median of one recruitment procedure.  
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Table 3. SVP Recruitment Summary. Median and range number of recruitment 
procedures at each stage were recorded to note the tendency of when recruitment is 
usually done before having BiVC. 
SVP: Palliation Stage Recruitment to 
BiVC, n (%) 
Value 
 
Stage 1 
Median Recruitment:  
Range of Recruitment: 
 
55 (100) 
1 
0-2 
BDG 
Median Recruitment:  
Range Recruitment: 
 
44 (80) 
1 
0-4 
 
Fontan  
Median Recruitment: 
10 (18) 
1 
 
BIV Conversion  
 In total, 39 HLHS patients (out of 55) ultimately had BiVC. Outcomes after BiVC 
are as following: 8 patients deceased and 31 patients survived. Of the 31 patients, 2 
patients had heart transplants, 2 patients had a biventricular takedown back to single 
ventricle circulation, and 21 patients had re-operations (53.8%).  
 
Table 4. BIV Conversion Outcomes. 8 patients deceased and 31 patients survived after 
BiVC.  
Outcomes, n (%) Value 
Deceased, n(%) 8 (21) 
Alive, n(%) 
Transplant:  
 
Takedown from biventricular 
31(79) 
2 (0.06)* 
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circulation to single ventricle 
circulation:  
 
 
Re-operations: 
2 (0.06)* 
 
21(68)* 
*Calculated out of 31 patients alive 
 
Trajectory of LV Growth  
 Overall, LV EDV and z-score increases at each sequential palliation stage. 
Median LV EDV increased from 3.74 ml to 8.71 mL, 18.0 ml, and finally 26.91 ml at 
Stage 1, BDG, Fontan, and BiVC, respectively. LV EDV median z-score increased from -
2.78 to -2.65, -1.86, and finally -0.81 at Stage 1, BDG, Fontan, and BiVC, respectively. 
The most improvement in LV EDV happens between BDG and Fontan, with a difference 
of 9.29 ml. The most improvement in z-score happens between Fontan and BiVC, with a 
difference of +0.795.  
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Figure 5. LV EDV and Z-score Overview throughout HLHS Journey. LV EDV had 
greatest improvement from BDG to Fontan with an increase of 9.29 ml. Z-score’s best 
improvement was between Fontan to BiVC with an increase of 0.795.  
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Figure 6. LV EDV Overview with interquartile range (IQR). Besides at BDG, the 
dispersion of most LV EDV values settles above the median. BiVC has the largest 
dispersion for these values while BDG has the smallest. 
 
Recruitment Procedures  
 Similar to above, choosing to focus on population at each stage for recruitment 
procedures performed will entail overlap. He or she may have had undergone recruitment 
procedures in both Stage 1 and BDG, but will be counted as one patient at each stage.  
 Recruitment procedures are done either in complement with the palliation surgery 
or separately. Twenty-three patients had recruitment in Stage 1, 29 patients for BDG, and 
5 patients for Fontan.  
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Figure 7. Probability of Recruitment at Each Palliation Stage.  
About half of the patients had at least one recruitment procedure at BDG.  
Majority of the patients have recruitment procedures done at BDG, followed  
by Stage 1 and then Fontan.  
 
Recruitment Effectiveness 
 Recruitment effectiveness was observed at each stage by comparing median z-
scores between patients who went straight to BiVC compared with patients who had LV 
recruitment procedures before BiVC. Z-score data was collected directly before a patient 
undergoes respective palliation surgery and immediately before BiVC.  
 Patients at Stage 1 who went straight to BiVC had a 135.6% increase in LV EDV 
z-score. Patients at Stage 1 who had recruitment procedures before BiVC had a 44.5% 
increase in LV EDV z-score. 
 Patients at BDG who went straight to BiVC had a 48.8% increase in LV EDV z-
score compared to a 90.4% increase for patients who had recruitment procedures at BDG 
before BiVC.  
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 Finally, the Fontan patient who went directly to BiVC had 0% increase LV EDV 
z-score while there was an observed 83.0% increase for Fontan patients with recruitment 
procedures before BiVC.  
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Figure 8. Recruitment Effectiveness. To measure the effectiveness of recruitment on 
LV growth, patients that had Stage 1 Norwood, BDG, and Fontan were compared with 
other patients who had same procedures except with recruitment all before directly going 
to BiVC. Recruitment effectiveness was most prominent at BDG. 
 
Specifics of LV Recruitment Procedures 
 LV Recruitment procedures consist of EFE Resection, ASD restriction (ASD 
Fenestration), and valve work (aortic and mitral valvuloplasty). Thirty-one out of the 55 
patients of patients had EFE Resection (56.4%), 28 had ASD fenestration (50.9%), and 
39 had valve work (70.9%). Patients can have multiple recruitment procedures done 
simultaneously. These numbers also include patient overlap for the same reasoning as he 
or she may have had undergone recruitment procedures in both Stage 1 and BDG, but 
will be counted as one patient at each stage.  
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Table 5. Breakdown of Recruitment Procedures 
Recruitment Procedure, n (%) Value 
ASD Fenestration 28 (51) 
Valve Work (AV/MV repair/replacement) 39 (71) 
EFE Resection   31 (56) 
 
EFE Resection 
 Percent of LV growth was calculated by median z-scores taken at the following 
time points: directly before EFE resection and right before the next procedure. It was then 
categorized by palliation stage when EFE resection was performed- Stage 1, BDG, and 
Fontan- but also included BiVC to further explore the significance and correlation of EFE 
and LV growth.  A 6.9% increase, 50.2% increase, 62.3% increase, and 206.1% increase 
in LV EDV z-score after EFE resection at Stage 1, BDG, Fontan, and BiVC, respectively.  
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Figure 9. Percentage of Growth after EFE Resection at SVP and BiVC. To judge if 
EFE was truly hindering LV growth, z-scores before and after EFE resection were 
measured and categorized to be either at Stage 1 Norwood, BDG, Fontan, or BiVC. Most 
LV growth occurs after EFE resection at BDG and Fontan compared to stage 1.  
 
Re-operations:  
 Twenty-one patients had re-operations after BiVC. Re-operation for mitral valve 
replacement and mitral valve repair was the most common. Two of the 21 patients had 
biventricular takedown back to SVP.  
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DISCUSSION 
 
In this report, we explore the overall trajectory of surgical care for HLHS patients 
at Boston Children’s Hospital while observing significant characteristics of this 
population at each stage- Stage 1, BDG, Fontan, BiVC. LV Recruitment was further 
evaluated to observe its impact on LV growth and function. EFE resection, a specific 
procedure part of staged LV Recruitment, was also discerned to show that EFE could 
hinder LV growth. All data recording for both prospective and retrospective patients 
ended on December 1, 2018.  
The main findings of this study is listed as the following:  
• BDG is the most critical stage in the SVP pathway  
• EFE Resection is most effective (or correlates to the most LV growth) at 
BDG and Fontan compared to Stage 1 
 
Limitations 
The decision to focus on population at each stage of SVP even if our patient 
population will overlap is to pinpoint what happens at that particular stage. This includes 
LV recruitment effectiveness on LV growth and characteristics that predict re-operations 
after BiVC, which both are measured by LV EDV and respective z-scores. Using this 
information, connections can be seen on how each stage affects the next (ie. BDG 
affecting Fontan results) or how it relates to previous stage (ie. how did Stage 1 help 
BDG be more successful). Overall, main conflict with data collection is attempting to 
obtain data, especially patients who were referred from outside hospitals. ECHO 
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measurements are often missing. To address data quality, patients were included only if 
LV EDV and respective z-scores were measured prior and after each surgical stage. Even 
if one of the two measurements were included, patients were excluded from data analysis 
at that stage. 
Another limitation to the study is the definition of true HLHS. True HLHS 
patients do not have ventricular septal defects (VSD). Patients who do have HLHS but 
have VSDs are considered HLHS variants.  Therefore, for the purpose of focusing on LV 
growth potential at each stage, HLHS variants were not excluded. This may affect the 
generalizability of the results of this study for true HLHS patients but still gives a good 
oversight of the effects after each palliation procedure. 
 
LV EDV and Z-Scores  
 In Figure 6, the dispersion of LV EDV values at BDG in relationship to that of 
Fontan is important to highlight. There is a larger LV EDV variance at Fontan, 
particularly above the median, than at BDG. This indicates that there must be significant 
improvements in LV growth after BDG to not only reflect a higher median EDV at 
Fontan, but also the increase in ratio of EDV values above the median. Thus, this 
reiterates the potential BDG holds to grow the LV. 
 
Recruitment Effectiveness 
Although there is a median of recruitment procedures of one for all stages to 
BiVC, the difference in range is most drastic in BDG (0 to 4) compared to Stage 1 (range 
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of 0 to 2) (Table 3). This shows that LV growth at BDG has the most potential because 
more recruitment procedures are being approved and performed, which relates to 
opportunities to stimulate LV growth. Through recruitment, it is only shown at BDG to 
be able to push for the most LV growth, with evidence that those who had recruitment at 
this procedure had a LV growth that exceeds those who did not have recruitment- 90.4% 
vs. 48.8% (Figure 8). 
 Next, a median recruitment of one at Fontan matches expectation; those who are 
on Fontan circulation usually do not proceed to BiVC. Therefore, the ability to do so	  
indicates that at Fontan, there are still possibilities of LV growth that meet the criteria for 
BiVC. Growth after recruitment on Fontan was 83.0%, close to growth of that of BDG 
patients (90.4%). 
Overall, recruitment effectiveness is best demonstrated at BDG. BDG patients 
with recruitment also experienced 45.9% more LV growth than patients at Stage 1 with 
recruitment and 7.4% more LV growth than patients at Fontan with recruitment (all going 
directly to BiVC) (Figure 8). One limiting factor for these results can be due to having 
two and three times the amount of patients (16 patients) than BDG (8 patients) and stage 
1 (5 patients), respectively; thus, more data obtained can assist accuracy and reliable 
results.  
  
Outcomes 
All patients at BDG with no recruitment had an outcome of BIV circulation with 
no re-operations. Contrarily, outcomes for patients with recruitment are as the following: 
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4 patients had 1 re-operation after BiVC, 2 patients had 2 re-operations after BiVC, 1 
patient had 3 re-operations after BiVC, 5 patients on BIV circulation without re-
operations, 2 deceased, and 2 transplanted. There is a positive correlation between 
number of recruitments and re-operations after BiVC. 
 
Table 6. Outcomes of BDG With and Without Recruitment 
Outcomes of BDG with Recruitment Number of Patients 
BiVC with No Re-operations 
BiVC with 1 Re-operation  
BiVC with 2 Re-operations  
BiVC with 3 Re-operations  
Deceased 
Transplanted 
5 
4 
2 
1 
2* 
2* 
*Patients also had re-operations before death or transplant 
Outcomes of BDG with No Recruitment Number of Patients 
BiVC with No Re-operations 4 
 
Stage 1 shows an opposite trend. Patients who did not have recruitment before 
going directly to BiVC experienced 91.1% more growth than patients who have 
recruitment and went directly to BiVC. It is usually expected if no recruitment is needed, 
then LV for these patients must be larger than that of patients who need recruitment; On 
the contrary, the z-scores at the beginning of stage 1 between both groups are similar 
(median z-score of -2.91 for no recruitment and -2.98 for recruitment patients). LV 
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growth has yet to achieve its full potential because children tend to undergo stage 1 in 
their first week of life (Roeleveld et al., 2018). Therefore, LV growth for one child might 
be more than the other.  
 Outcomes at stage 1 for no recruitment patients are as following: 2 patients on 
BIV circulation with no re-operations, 1 patient with 1 re-operation after BiVC, 1 patient 
deceased, and 1 patient on a 1.5 ventricular circulation (1.5V). 1.5V, also known as “one 
and one-half ventricle repair”, is when pulmonary ventricle (RV) is recruited to manage 
part of the systemic venous return, as there is RV hypoplasia and dysfunction 
(Chowdhury et al., 2005). Outcomes for recruitment patients are as following: 4 patients 
with 1 re-operation after BiVC, 1 deceased, and 3 patients with no re-operation after 
BiVC. The positive correlation between number of recruitments and re-operations after 
BiVC is consistent at this stage.  
 
Table 7. Outcomes for Stage 1 Norwood With and Without Recruitment 
Outcomes for Stage 1 with Recruitment Number of Patients  
BiVC with No Re-operations 
BiVC with 1 Re-operation  
Deceased 
3 
4 
1 
 
Outcomes for Stage 1 with No Recruitment Number of Patients 
BiVC with No Re-operations 
BiVC with 1 Re-operation 
2 
1 
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BiVC to 1.5V  
Deceased 
1 
1* 
*Patient had a takedown from BIV to SVP 
At the other end of the spectrum, optimal time for Fontan surgery is considered to 
be between 2 and 3 years of age because older age at Fontan completion has been 
associated with worse exercise capacity and hemodynamics, aorticventricular valve 
regurgitation, and deteriorating diastolic function (Lytrivi et al., 2011). Outcomes for 
Fontan with recruitment are the following: 2 deceased and 3 patients with no re-
operations after BiVC. The only outcome for Fontan and no recruitment is deceased. 
These results do not indicate the same trend of positive correlation between numbers of 
recruitments to re-operations, but does indicate correlation between death and Fontan 
with recruitment. With the side effects of Fontan being well known, recruitment 
performed may worsen the effects and compromise LV function. 
 
Table 8. Outcomes for Fontan With and Without Recruitment 
Outcomes for Fontan with Recruitment Number of Patients 
Deceased  
BiVC with No Re-operations 
2* 
3 
*1 patient had 1 re-operation after BiVC 
Outcomes for Fontan without Recruitment Number of  Patients 
Deceased 1 
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Re-operations: 
Patients that did not have recruitment at stage 1 and ended with BIV circulation 
without re-operation displayed an initial LV EDV median z-score of -2.91. Compared to 
patients with the same outcome but who had recruitment, the initial LV EDV median z-
score was -2.78. Since their z-scores are similar, it can be assumed that a z-score within 
this range indicates association with no- reoperation after BiVC. The median z-score for 
those who did have re-operation after BiVC is -3.18. A more negative z-score indicates a 
smaller left ventricle; Therefore, an assumption is that the smaller the left ventricle is at 
stage 1 undergoing recruitment procedures, the higher the association with re-operation 
after BiVC. 
 At BDG, the results were opposite from that of stage 1. The more negative the z-
score is at BDG operation, the more likely it is associated with no re-operation after 
BiVC. A median z-score of  -5.11 was observed. The median z-scores associated with re-
operation after BiVC for both recruitment and no recruitment patients were -1.42 and -
1.64, respectively. Therefore, a range between a z-score of -1 and -2 could be a point of 
interest associated with re-operation. The assumption at BDG comparing a z-score of       
-5.11 to -1.42 and -1.64 indicates that the smaller the left ventricle is, the increase in 
association with no re-operation after BiVC. Overall, BDG is the ideal situation; it shows 
that we can truly grow the left ventricle from an abnormally small left ventricle (z-score 
of -5.11) with minimal side effects.  
 At Fontan, the outcomes are either BIV circulation with no re-operation or 
deceased. A more positive z-score (-0.44 and -0.88 for recruitment and no recruitment 
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patients, respectively) has an association with death. A more negative z-score (-2.66 for 
recruitment patients) is associated with BIV circulation with no re-operation. This is 
similar to the results from BDG. 
 
EFE 
 The highest percentage of LV growth after EFE resection is at BiVC (Figure 9). 
There is a 206.1% in LV growth compared to 6.9%, 50.2%, and 62.3% at Stage 1, BDG, 
and Fontan, respectively. For SVP, EFE resection is most effective at BDG and Fontan 
compared to Stage 1. Although BiVC had a higher increase in LV growth compared to 
BDG and Fontan, the more accurate conclusion for Figure 9 about EFE resection’s 
effectiveness would be at SVP. This is due to the inconsistency of time points for data 
collection at BiVC. BiVC is the end procedure for many of the patients and 
measurements taken to evaluate impact of EFE resection were before BiVC and prior to 
re-operation. If there were no re-operation, the latest ECHO before December 1, 2018 
would be used to assess for results. Therefore, the time period between BiVC and re-
operation and/or latest ECHO on file varies significantly across all patients. 
Measurements were taken this way to observe the full potential of LV growth after EFE 
resection. Compared to SVP, time period between data collection procedures do not have 
as much variance because procedures are performed usually around recommended ages - 
stage 1 Norwood procedure in the first week of life, BDG at 4-6 months of life, and 
Fontan at 2-4 years of age (Roeleveld et al., 2018).  
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Furthermore, another limitation is EFE resection is often times being performed 
with valve work and /or ASD fenestration. There may be a possibility of a particular 
combination of the three techniques that may influence LV growth more significantly. 
Nonetheless, this data overall shows that EFE truly hinders LV growth and more so at 
subsequent palliation stages.   
 
Conclusion  
 In conclusion, BDG is the most critical stage for LV growth. LV EDV shows the 
most improvement and recruitment is the most effective at BDG. Furthermore, we are 
able to show the recruitment procedures were able to affect growth of the small LV that 
exceeds LV growth with no recruitment (Figure 8). However, recruitment done at BDG is 
also strongly associated with an increase in re-operations. This can be due to the interplay 
of age and time recruitment is performed; these patients may be at an age that potential 
for adaptability and resilience is at its highest, but can act as a double-edged sword when 
this vulnerability causes the most side effects. 
 EFE resection is most effective at BDG and Fontan compared to stage 1,which 
indicates EFE is strongly correlated with increased hindrance of LV growth potential in 
the long-term. EFE resection’s promising results help reevaluate perspective on the 
importance of this recruitment procedure at the later stages despite knowing SVP’s long-
term negative effects on the heart. Recruitment and EFE resection at Fontan has also been 
impressive. With an 83.0% and 62.3% in improvement for LV EDV z-score for 
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recruitment and EFE resection, respectively, there remains potential for LV growth at 
Fontan. 
 
Further Studies 
 Further points that can be explored are predictive factors besides LV EDV and 
respective z-scores for estimating LV growth, combinations of recruitment techniques 
that draw a bigger difference in LV enlargement, and patterns in surgical techniques that 
are correlated with reduced number of re-operations. More investigation can also be 
drawn to Fontan and successful LV growth. Although long-term effects on Fontan 
circulation are proven, the LV growth potential at this stage should be explored and 
weighed with risks. More detailed studies on correlation between BDG and LV growth, 
such as predictive factors and patterns between patients, are also subjects that may be of 
interest. The amount of re-operations at BDG are also worthy to be noted.  Moreover, 
another suggestion for further study is to analyze the results of true HLHS patients. Not 
only will it improve the application of this study to HLHS patients, it can more accurately 
pinpoint specific significant factors that may have gone unnoticed.  
 
 	  	  	  	  	  	  	  	  
	  33 
REFERENCES 
 
Banka, P., Schaetzle, B., Komarlu, R., Emani, S., Geva, T., & Powell, A. J. (2014). 
Cardiovascular magnetic resonance parameters associated with early transplant-
free survival in children with small left hearts following conversion from a 
univentricular to biventricular circulation. Journal of Cardiovascular Magnetic 
Resonance, 16(1). https://doi.org/10.1186/s12968-014-0073-1 
Chowdhury, U. K., Airan, B., Talwar, S., Kothari, S. S., Saxena, A., Singh, R., … 
Venugopal, P. (2005). One and one-half ventricle repair: results and concerns. 
The Annals of Thoracic Surgery, 80(6), 2293–2300. 
https://doi.org/10.1016/j.athoracsur.2005.05.052 
Emani, S. M., McElhinney, D. B., Tworetzky, W., Myers, P. O., Schroeder, B., 
Zurakowski, D., … del Nido, P. J. (2012). Staged Left Ventricular Recruitment 
After Single-Ventricle Palliation in Patients With Borderline Left Heart 
Hypoplasia. Journal of the American College of Cardiology, 60(19), 1966–1974. 
https://doi.org/10.1016/j.jacc.2012.07.041 
Gładki, M. M., Składzień, T., & Skalski, J. H. (2015). The impact of environmental 
factors on the occurrence of congenital heart disease in the form of hypoplastic 
left heart syndrome. Kardiochirurgia i Torakochirurgia Polska = Polish Journal 
of Cardio-Thoracic Surgery, 12(3), 204–207. 
https://doi.org/10.5114/kitp.2015.54455 
Human, D. G. (2009). Living with complex congenital heart disease. Paediatrics & Child 
Health, 14(3), 161–182. 
	  34 
Kalish, B. T., Banka, P., Lafranchi, T., Tworetzky, W., Nido, P. del, & Emani, S. M. 
(2013). Biventricular Conversion After Single Ventricle Palliation in Patients 
With Small Left Heart Structures: Short-Term Outcomes. The Annals of Thoracic 
Surgery, 96(4), 1406–1412. https://doi.org/10.1016/j.athoracsur.2013.05.060 
Lytrivi, I. D., Sfyridis, P. G., Papagiannis, J., Kirvassilis, G., Zavaropoulos, P., & Sarris, 
G. E. (2011). Impact of age at fontan completion on functional status at mid-term 
follow up. Hellenic Journal of Cardiology: HJC = Hellenike Kardiologike 
Epitheorese, 52(2), 118–122. 
Mettler, B. A., & Pigula, F. A. (2016). Hypoplastic Left Heart Syndrome. In F. W. Selle, 
P. J. del Nido, & S. J. Swanson (Eds.), SABISTON AND SPENCER SURGERY 
OF THE CHEST (9th ed., Vol. 2, pp. 2295–2312). Elsevier, Inc. 
Oladunjoye, O. O., Piekarski, B., Banka, P., Marx, G., Breitbart, R. E., Nido, P. J. del, & 
Emani, S. M. (2018). Staged ventricular recruitment in patients with borderline 
ventricles and large ventricular septal defects. The Journal of Thoracic and 
Cardiovascular Surgery, 156(1), 254–264. 
https://doi.org/10.1016/j.jtcvs.2018.03.111 
Oster, M. E., Kelleman, M., McCracken, C., Ohye, R. G., & Mahle, W. T. (2016). 
Association of Digoxin With Interstage Mortality: Results From the Pediatric 
Heart Network Single Ventricle Reconstruction Trial Public Use Dataset. Journal 
of the American Heart Association, 5(1). 
https://doi.org/10.1161/JAHA.115.002566 
	  35 
Roeleveld, P. P., Axelrod, D. M., Klugman, D., Jones, M. B., Chanani, N. K., Rossano, J. 
W., & Costello, J. M. (2018). Hypoplastic left heart syndrome: from fetus to 
fontan. Cardiology in the Young, 28(11), 1275–1288. 
https://doi.org/10.1017/S104795111800135X 
Shimada, S., Robles, C., Illigens, B. M. W., Casar Berazaluce, A. M., del Nido, P. J., & 
Friehs, I. (2015). Distention of the Immature Left Ventricle Triggers 
Development of Endocardial Fibroelastosis: An Animal Model of Endocardial 
Fibroelastosis Introducing Morphopathological Features of Evolving Fetal 
Hypoplastic Left Heart Syndrome. BioMed Research International, 2015. 
https://doi.org/10.1155/2015/462469 
Toebbe, S., Yehle, K., Kirkpatrick, J., & Coddington, J. (2013). Hypoplastic Left Heart 
Syndrome: Parent Support for Early Decision Making. Journal of Pediatric 
Nursing, 28(4), 383–392. https://doi.org/10.1016/j.pedn.2012.11.005 
Ursell, P. C., Neill, C. A., Anderson, R. H., Ho, S. Y., Becker, A. E., & Gerlis, L. M. 
(1984). Endocardial fibroelastosis and hypoplasia of the left ventricle in neonates 
without significant aortic stenosis. British Heart Journal, 51(5), 492–497. 
  
	  36 
CURRICULUM VITAE 
	  37 
	  38 
	  39 
